Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;20(6):360-8.
doi: 10.1258/vasc.2011.201205. Epub 2012 Oct 19.

Cell-based interventions for therapeutic angiogenesis: review of potential cell sources

Robert A Brenes  1 , Mackenzie Bear, Caroline Jadlowiec, Matthew Goodwin, Peter Hashim, Clinton D Protack, Kenneth R Ziegler, Xin Li, Lynn S Model, Wei Lv, Michael J Collins, Alan Dardik
Affiliations
Review

Cell-based interventions for therapeutic angiogenesis: review of potential cell sources

Robert A Brenes et al. Vascular. 2012 Dec.

Abstract

Alternative therapies are currently being developed to treat patients with chronic limb ischemia who are unable to be revascularized in order to avoid amputation. Cell-based therapy using mononuclear cells is gaining attention as many clinical trials are currently underway. We review cell differentiation along with the different potential cell sources for use in therapeutic angiogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hematopoietic stem cell (HSC) differentiation Legend: CFU=colony forming unit
Figure 2
Figure 2
Endothelial progenitor cell (EPC) transit from the bone marrow to the periphery
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg. 2007;45(Suppl S):S5–67. - PubMed
    1. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation. 1999;99(1):111–20. - PubMed
    1. Rajagopalan S, Mohler ER, 3rd, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003;108(16):1933–8. - PubMed
    1. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360(9331):427–35. - PubMed
    1. Miyamoto K, Nishigami K, Nagaya N, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation. 2006;114(24):2679–84. - PubMed

Publication types